Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF394 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AKIRIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PABPC1L2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930107 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RELL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB39B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCSK7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUCA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C15orf40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on